Scarica l'app Stockscreener
49.25
0.38%
-0.19
Dopo l'orario di chiusura:
49.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$49.44
Aprire:
$49.03
Volume 24 ore:
343.26K
Relative Volume:
0.81
Capitalizzazione di mercato:
$1.48B
Reddito:
$1.37B
Utile/perdita netta:
$54.85M
Rapporto P/E:
27.78
EPS:
1.7729
Flusso di cassa netto:
$123.71M
1 W Prestazione:
+5.42%
1M Prestazione:
+7.53%
6M Prestazione:
+31.33%
1 anno Prestazione:
+2.05%
Intervallo 1D:
$48.31
$49.72
Intervallo di 1 settimana:
$45.81
$49.72
Portata 52W:
$31.44
$53.66
Conmed Corp Stock (CNMD) Company Profile
Nome
Conmed Corp
Settore
Industria
Telefono
727-214-2974
Indirizzo
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
49.25 | 1.48B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2026-06-29 | Downgrade | BofA Securities | Neutral → Underperform |
| 2026-03-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | Downgrade | Needham | Buy → Hold |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-02-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Reiterato | Needham | Buy |
| 2023-05-22 | Iniziato | CL King | Buy |
| 2023-03-27 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-10-06 | Aggiornamento | Needham | Hold → Buy |
| 2021-07-15 | Iniziato | UBS | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2019-11-26 | Downgrade | Needham | Buy → Hold |
| 2019-11-12 | Iniziato | JP Morgan | Overweight |
| 2019-10-31 | Reiterato | Needham | Buy |
| 2019-10-04 | Reiterato | Needham | Buy |
| 2019-08-22 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Iniziato | Stifel | Buy |
| 2019-04-16 | Reiterato | Needham | Buy |
| 2019-01-23 | Reiterato | Needham | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-08-07 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-02-01 | Reiterato | Needham | Buy |
| 2017-07-27 | Reiterato | Needham | Buy |
| 2017-04-27 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-11-18 | Reiterato | Needham | Buy |
| 2016-07-28 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Reiterato | Needham | Buy |
| 2015-10-22 | Reiterato | Northland Capital | Market Perform |
Mostra tutto
Conmed Corp Borsa (CNMD) Ultime notizie
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
CONMED Corporation $CNMD Stake Reduced by Cooke & Bieler LP - MarketBeat
A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $45 to $46 - Moomoo
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
CONMED Corporation (CNMD) Stock forecasts - Yahoo Finance Singapore
CONMED Corporation (NYSE:CNMD) Stock Has Average Price Target of $41.40 - MarketBeat
CONMED Corporation (CNMD) Stock Forecasts - Yahoo! Finance Canada
Conmed Corp (EC8.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
CONMED (NYSE:CNMD) Shares Gap DownHere's Why - MarketBeat
Is Conmed Corp (CNMD) a Bargain After 6.0% Drop? GF Value Says U - GuruFocus
Conmed Corp (EC8.SG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
CONMED stock gains 2.22 percent ahead of October 28 results - AD HOC NEWS
CONMED stock trades at EUR 41.30 ahead of results - AD HOC NEWS
CONMED stock heads into October 28 results with EPS guidance - AD HOC NEWS
Surgical Equipment & ConsumablesDiversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD) - Yahoo Finance
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Orthopedics This Week
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Orthopedics This Week
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Business Wire
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026 - Yahoo Finance
CONMED: Flat Sales, Better Cash, and a More Interesting Story - Orthopedics This Week
CONMED: Flat Sales, Better Cash, and a More Interesting Story - Orthopedics This Week
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
CONMED Corporation (CNMD) Stock forecasts - Yahoo Finance UK
Discipline and Rules-Based Execution in CNMD Response - Stock Traders Daily
CONMED Corporation (CNMD) Stock Forecasts - Yahoo! Finance Canada
Bank of America Corp DE Acquires Shares of 1,341,409 CONMED Corporation $CNMD - MarketBeat
Conmed Corp (EC8.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Conmed Stock Price Forecast. Should You Buy CNMD? - StockInvest.us
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - finance.yahoo.com
CONMED Director Kim Kelderman Awarded 500 RSUs Under 2025 Long-Term Incentive Plan - Kalkine Media
CONMED (CNMD) director receives 500 shares as stock units vest - Stock Titan
CONMED at Wells Fargo conference: growth story gains momentum By Investing.com - Investing.com India
CONMED at Wells Fargo conference: growth story gains momentum By Investing.com - Investing.com UK
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform? - Zacks Investment Research
Legal & General Group Plc Purchases New Shares in CONMED Corporation $CNMD - MarketBeat
291,203 Shares in CONMED Corporation $CNMD Acquired by Bank of New York Mellon Corp - MarketBeat
CNMD stock slips after Q2 2026 beat as med-tech investors watch guidance - AD HOC NEWS
CONMED Corporation stock gains support from solid earnings and guidance - ad-hoc-news.de
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in CONMED Corporation $CNMD - MarketBeat
Deutsche Bank AG Buys Shares of 32,796 CONMED Corporation $CNMD - MarketBeat
BlackRock Inc. Invests $157.78 Million in CONMED Corporation $CNMD - MarketBeat
Technical Reactions to CNMD Trends in Macro Strategies - Stock Traders Daily
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Algert Global LLC Has $4.30 Million Position in CONMED Corporation $CNMD - MarketBeat
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference - finance.yahoo.com
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference - Business Wire
Paradigm Capital Management Inc. NY Purchases New Position in CONMED Corporation $CNMD - marketbeat.com
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead - Yahoo Finance
CONMED (NYSE:CNMD) Draws Focus After Strong Results - Kalkine Media
CONMED (CNMD): Finishes 1.34% Lower at $50.63 in the Current Update; Key Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseBollinger Squeeze - vinanet.vn
Conmed Corp Azioni (CNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Conmed Corp Azioni (CNMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bronson David M. | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
17,909 |
| Council LaVerne H | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
4,716 |
| Farkas Charles | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
15,527 |
| Kaye Mark | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
820 |
| Schwarzentraub Barbara J | Director |
Jun 02 '26 |
Option Exercise |
0.00 |
668 |
0 |
5,012 |
| Lalomia Brent | Executive VP RA, QA |
Mar 06 '26 |
Option Exercise |
0.00 |
75 |
0 |
941 |
| Kaye Mark | Director |
Feb 24 '26 |
Option Exercise |
0.00 |
152 |
0 |
152 |
| Glaze Richard | Chief Information Officer |
Nov 21 '25 |
Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Officer |
Nov 21 '25 |
Proposed Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Chief Information Officer |
Nov 20 '25 |
Option Exercise |
0.00 |
375 |
0 |
375 |
2.78%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):